Therefore, this HFF-STZ murine model represents an ideal tool to fully explore the positive effects of peptide-based GCGR antagonists in obesity-driven forms of diabetes, where restoration of functional beta-cell mass would be highly advantageous. Here, GCGR is linked to obesity disorder.